These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31217523)

  • 61. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
    Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical epidemiology, treatment and prognostic factors of extensively drug-resistant Acinetobacter baumannii ventilator-associated pneumonia in critically ill patients.
    Tsioutis C; Kritsotakis EI; Karageorgos SA; Stratakou S; Psarologakis C; Kokkini S; Gikas A
    Int J Antimicrob Agents; 2016 Nov; 48(5):492-497. PubMed ID: 27542315
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetic evaluation of colistin sodium.
    Michalopoulos AS; Karatza DC; Gregorakos L
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):245-55. PubMed ID: 21128824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Colistin use in critically ill neonates: A case-control study.
    İpek MS; Aktar F; Okur N; Celik M; Ozbek E
    Pediatr Neonatol; 2017 Dec; 58(6):490-496. PubMed ID: 28501490
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium.
    Hassan MM; Gaifer Z; Al-Zakwani IS
    Int J Clin Pharm; 2018 Apr; 40(2):444-449. PubMed ID: 29542034
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Risk factors for the first episode of
    Mantzarlis K; Makris D; Zakynthinos E
    J Med Microbiol; 2020 Jan; 69(1):35-40. PubMed ID: 31647404
    [No Abstract]   [Full Text] [Related]  

  • 68. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pharmacokinetic/Toxicodynamic Analysis of Colistin-Associated Acute Kidney Injury in Critically Ill Patients.
    Forrest A; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Paterson DL; Li J; Silveira FP; Nation RL
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893780
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis.
    Gu WJ; Wang F; Tang L; Bakker J; Liu JC
    Int J Antimicrob Agents; 2014 Dec; 44(6):477-85. PubMed ID: 25199968
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.
    Abdellatif S; Trifi A; Daly F; Mahjoub K; Nasri R; Ben Lakhal S
    Ann Intensive Care; 2016 Dec; 6(1):26. PubMed ID: 27033711
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?
    Sorli L; Luque S; Li J; Rodríguez E; Campillo N; Fernandez X; Soldado J; Domingo I; Montero M; Grau S; Horcajada JP
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717123
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of aerosolized colistin as adjunctive treatment on the outcomes of microbiologically documented ventilator-associated pneumonia caused by colistin-only susceptible gram-negative bacteria.
    Tumbarello M; De Pascale G; Trecarichi EM; De Martino S; Bello G; Maviglia R; Spanu T; Antonelli M
    Chest; 2013 Dec; 144(6):1768-1775. PubMed ID: 23989805
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Good tolerability of high dose colistin-based therapy in patients with haematological malignancies.
    Grignolo S; Tatarelli P; Guolo F; Minetto P; Rivoli G; Guardo D; Del Bono V; Varaldo R; Gualandi F; Ballerini F; Raiola A; Gobbi M; Viscoli C; Mikulska M
    Infection; 2017 Aug; 45(4):505-511. PubMed ID: 28353153
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study.
    Benattar YD; Omar M; Zusman O; Yahav D; Zak-Doron Y; Altunin S; Elbaz M; Daitch V; Granot M; Leibovici L; Paul M
    Clin Infect Dis; 2016 Dec; 63(12):1605-1612. PubMed ID: 27794023
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparison of nephrotoxicity of Colistin with Polymyxin B administered in currently recommended doses: a prospective study.
    Aggarwal R; Dewan A
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):15. PubMed ID: 29571295
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravenous plus inhaled versus intravenous colistin monotherapy for lower respiratory tract infections: A systematic review and meta-analysis.
    Vardakas KZ; Mavroudis AD; Georgiou M; Falagas ME
    J Infect; 2018 Apr; 76(4):321-327. PubMed ID: 29428226
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.
    Durante-Mangoni E; Signoriello G; Andini R; Mattei A; De Cristoforo M; Murino P; Bassetti M; Malacarne P; Petrosillo N; Galdieri N; Mocavero P; Corcione A; Viscoli C; Zarrilli R; Gallo C; Utili R
    Clin Infect Dis; 2013 Aug; 57(3):349-58. PubMed ID: 23616495
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
    Ooi MH; Ngu SJ; Chor YK; Li J; Landersdorfer CB; Nation RL
    Clin Infect Dis; 2019 Nov; 69(11):1962-1968. PubMed ID: 30722017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.